How Biogen and Other Biopharma Companies Are Responding to COVID-19

It was reported earlier that 15 employees of Cambridge, Massachusetts-based Biogen who attended a management meeting in Boston have now tested positive for the virus. The numbers are rapidly increasing, however. The company, which does not focus on infectious diseases, vaccines or antiviral therapies, but rather on neurodegenerative diseases like Alzheimer’s, spinal muscular atrophy and multiple sclerosis, is nonetheless an indicator of the perils companies that are working on responses to the coronavirus outbreak are facing—and the ways in which the virus can spread after a public gathering.